Forma Therapeutics Holdings, Inc. reported unaudited financial results for the first quarter ended March 31, 2021. Loss from operations was $36,210,000 against $32,226,000 a year ago. Net loss was $35,960,000 against profit of $11,230,000 a year ago. Net loss per basic share was $0.76 against profit of $2.29 a year ago. Net loss per diluted share was $0.76 against profit of $0.36 a year ago.